Versant Capital Management’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q1
Sell
-81
Closed 1790
2019
Q4
$0 Buy
+81
New ﹤0.01% 1659